EMA to scrutinize Ebola drugs
This article was originally published in Scrip
Executive Summary
With no medicines approved anywhere to treat Ebola but the potential need for healthcare providers to have to make a decision on whether to use an experimental product to treat a patient with the virus, European regulators on 26 September said they plan to scrutinize investigational products currently in the pipeline.